AbbVie
ABBV
#30
Rank
$294.49 B
Marketcap
$166.65
Share price
-1.76%
Change (1 day)
20.71%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): $7.06 Billion USD

According to AbbVie's latest financial reports the company's current earnings are $55.00 Billion USD. In 2023 the company made an earning of $6.25 Billion USD a decrease over its 2022 earnings that were of $13.47 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $7.06 B13.06%
2023 $6.25 B-53.62%
2022 $13.47 B3.76%
2021 $12.98 B282.25%
2020 $3.39 B-59.67%
2019 $8.42 B62.13%
2018 $5.19 B-32.74%
2017 $7.72 B-1.99%
2016 $7.88 B18.65%
2015 $6.64 B180.5%
2014 $2.36 B-55.57%
2013 $5.33 B-6.86%
2012 $5.72 B56.05%
2011 $3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$1.22 Billion-117.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.88 Billion-197.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.15 B 43.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.67 B-33.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.53 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.31 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.17 B-40.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.40 B 33.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.65 B-90.71%๐Ÿ‡บ๐Ÿ‡ธ USA